Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

4 treatments under study, led by Observation

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1/2 (1)

Trial Status

Recruiting1
Completed1
Terminated1
Unknown1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT06237010CompletedPrimary

Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel

NCT05805696Not ApplicableUnknownPrimary

Treatment and Mapping of Impostor Phenomenon

NCT05890092Recruiting

Vulvar Disease in Nigeria Observational Study

NCT00129415Phase 1/2Terminated

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Showing all 4 trials

Research Network

Common Treatments

  • Observation1
  • Impostor Tasks1
  • Uva1 Irradiation1
  • Uvb Irradiation1

Active Sponsors

  • Centre Hospitalier Intercommunal Creteil1
  • KDRS ltd1
  • University of Michigan1
  • Umeå University1

Top Investigators

Related Conditions

  • Mycosis Fungoides1
  • Hyperhidrosis1
  • Urticaria1
  • Pain Syndrome1
  • Stretch Marks1

Activity Timeline